Select a State Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin Wyoming

Texas

Walgreens pharmacist Aimee Lusson testified at the House Public Health Committee on March 27 in support of HB 2088 by Rep. John H. Bucy III (D), on emergency insulin supply legislation. 

Also in Texas, Rep. Tom Oliverson's HB 1543, legislation establishing a statewide standing order for prescribing an opioid antagonist, will be heard in the House Public Health Committee on April 3. 

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2023-03-31T09:31:23-04:00March 31, 2023|Texas|

Texas

To show legislators that this year pharmacies are a united front on PBM issues, NACDS submitted a support letter to the Texas House Insurance Committee on PBM ERISA reform legislation being led by the Texas Pharmacy Association and the Texas Pharmacy Business Council, HB 2021. A hearing was held on March 21.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2023-03-24T09:51:26-04:00March 24, 2023|Texas|

Texas

The deadline to file bills was Friday, March 10th.

Also in Texas, Rep. Julie Johnson (D) filed HB 3774, legislation providing pharmacists with liability protections when dispensing certain medications that could be used for an abortion.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2023-03-17T11:19:33-04:00March 17, 2023|Texas|

Texas

Legislation has been filed in both the House and Senate that would prohibit the Health and Human Services Commission’s Vendor Drug Program from including any discount price offered for the prescription drug, including a discount offered through a third-party discount card when defining the price of a prescription drug for purposes of determining the Usual and Customary (U&C) reimbursement rate for Medicaid. These bills include SB 1619 by Sen. Charles Perry (R) and HB 3214 by Rep. Donna Howard (D).

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2023-03-10T11:01:35-05:00March 10, 2023|Texas|

Texas

Rep. Dr. Tom Oliverson (R), chair of the House Insurance Committee, filed HB 2021, legislation that applies existing law intended to protect patients and pharmacies to all PBMs operating in Texas. The PBMs and Health plans are orchestrating opposition leveraging the Texas Association of Business and the Texas State Chamber of Commerce, mounting an aggressive campaign saying that preempting ERISA hurts employer's ability to offer quality, affordable health care and prescription options that best fit the needs of their employees. 

Also in Texas, NACDS and Texas Federation of Drug Stores (TFDS) pharmacists and interns from HEB and Walgreens spent time at the Capitol meeting with new members and staff to educate them on pharmacy's priority issues: Medicaid reimbursement rate floor and making the PREP Act flexibilities permanent by lowering the age to 3 years for pharmacists and pharmacy technicians to administer vaccinations without a prescription.  

Finally, the House Public Health Committee convened an organizational meeting on February 27 to discuss an organizational meeting and will be taking invited testimony from the Texas State Board of Pharmacy (TSBP), the Texas Department of State Health Services, and the Texas Health and Human Services Commission. 

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2023-03-03T10:13:14-05:00March 3, 2023|Texas|

Texas

House Speaker Dade Phelan (R) announced committee assignments this week.  

Also in Texas, Sen. Pete Flores (R) filed SB 749, legislation making permanent the Public Readiness and Emergency Preparedness Act (PREP Act) authority that authorizes pharmacists to both order and administer routine immunizations for individuals three years of age and older. The House companion bill is HB 1105 by Rep. Four Price (R). 

Also in Texas, Rep. Jacey Jetton (R) filed HB 2079, legislation would allow pharmacists to furnish medications for flu, strep and COVID as a result of a positive CLIA-waived test.  

Also in Texas, NACDS is a sponsor of Texas Pharmacy Day at the Capitol on February 28. This is a great opportunity for pharmacists from all practice settings to show unity promoting our legislative agenda. Space is limited, so register now. 

Finally in Texas, after a closed-door session at the quarterly meeting of the State Board of Pharmacy this week, the Board terminated the Executive Director Tim Tucker. 

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2023-02-10T09:44:45-05:00February 10, 2023|Texas|

Texas

The state legislature will convene its 140-day biennial session on January 10, 2023. Rep. Dade Phelan (R) was elected Speaker of the House. 

Also in Texas, the State Comptroller Glenn Hegar (R) announced on January 9 that the state has a $32.7 billion surplus.  

Also in Texas, the Health and Human Services Commission's (HHSC) Executive Commissioner Cecile Erwin Young announced that Dr. Jennifer Shuford would serve as Commissioner of the Texas Department of State Health Services (DSHS), replacing Dr. John Hellerstedt. Previously Shuford served as chief state epidemiologist at DSHS. 

Finally in Texas, several bills of interest to pharmacies have been filed: 

  • HB 1105 by Rep. Four Price (R) would make permanent the Public Readiness and Emergency Preparedness Act (PREP Act) authority that authorizes pharmacists to both order and administer routine immunizations for individuals three years of age and older.  
  • HB 1293 by Rep. Toni Rose (D), the Medicaid transparency reimbursement bill, would establish a rate floor for Medicaid MCOs. 
  • SB 160 by Sen. Charles Perry (R) would provide for pharmacists to furnish medications for flu, strep and COVID under a written protocol with additional training, if identified through a CLIA Waived test. Also, it would allow for a physician to dispense drugs for flu, step and COVID, if identified through a CLIA-waived test, and dispense all antibiotics and drugs authorized under an emergency rule. 

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2023-01-13T11:55:37-05:00January 13, 2023|Texas|
Go to Top